KODK · Eastman Kodak Company · Stock research

Current Thesis

The fat pitch has already been paid, and the tape is now confirming it. Kodak's $1.023B KRIP pension reversion completed December 2, 2025 ~$767M reverted, the term loan cut to a $200M balance, FY2025 cash $337M (+$136M YoY), net-cash for the first time in a decade. That de-risking drove a ~$6 March base to a $14.87 52-week high on May 4, 2026. The move has since fully unwound: the stock corrected through the June $9.06 low, lost the $9.00 shelf the last read flagged, and trades ~$7.78 (July 16, 2026), down ~48% from the high, with a fresh $4.94 52-week low now on the tape. Two July catalysts sealed the reversal a July 1 resale registration covering up to ~39.46M shares (secondary; the company receives no proceeds, pure overhang) and a June 29 Weiss Ratings downgrade to Sell (D+). What remains is an early, unsigned battery-electrode and pharma-reagent pivot inside Advanced Materials & Chemicals (AM&C revenue only +3% YoY in Q1) with no named offtake and a binary Q2 print on August 11. This is a broken structure under a dilution overhang heading into earnings a value-trap dip, not an accelerating setup. Fresh entries here are a pass until it bases and reclaims.

Bullish and bearish views on Eastman Kodak Company

The model's bull view on Eastman Kodak Company (KODK), in brief: Balance sheet repaired, not narrated: the Dec 2, 2025 reversion freed $1.023B; ~$767M reverted, the term loan cut to $200M, FY2025 cash $337M (+$136M YoY) against a $300M term loan + Series B preferred leaves the company net-cash. The bear view: The binary already paid and the trend is spent: reversion closed Dec 2, 2025, the re-rate topped at $14.87 on May 4, and the stock is now ~48% below that high with a $4.94 52-week low printed. Both cases follow in full.

Bull Case

• Balance sheet repaired, not narrated: the Dec 2, 2025 reversion freed $1.023B; ~$767M reverted, the term loan cut to $200M, FY2025 cash $337M (+$136M YoY) against a $300M term loan + Series B preferred leaves the company net-cash. A Q1 $46M cash inflow from KRIP reversion investments (reported May 7, 2026) keeps that liquidity building.
• Operating inflection multiple quarters deep: Q4 2025 (reported Mar 13, 2026) revenue $290M (+9%), operational EBITDA $22M (+144%); Q1 2026 (reported May 7, 2026) revenue $265M (+7% from $247M), gross margin 22% vs 19%, operational EBITDA $15M vs $2M.
• Pivot has product in pilots: the March 23, 2026 Ateios/RaiCore expansion took the battery-electrode platform to LCO/LFP/NMC with third-party PFAS-free verification (<20ppm organic fluorine vs a 100ppm threshold), 4th-gen electrodes at >98% active-material loading, and OEM pilot programs;
• Legacy base still growing: Print revenue $180M in Q1 2026 (+9% YoY) the imaging core is funding the pivot rather than collapsing on the timeline bears modeled.
• Special-situation optionality: a net-cash balance sheet makes an AM&C carve-out or strategic review more credible than at any point in the past decade.

Bear Case

• The binary already paid and the trend is spent: reversion closed Dec 2, 2025, the re-rate topped at $14.87 on May 4, and the stock is now ~48% below that high with a $4.94 52-week low printed. Buying ~$7.78 is paying after the event for a second leg that needs a new, un-named catalyst.
• Fresh dilution overhang: the July 1, 2026 resale registration covers up to ~39.46M shares (plus 4.43M selling-holder shares) for secondary resale with no proceeds to the company a live supply cap that took the stock down ~10% on July 2 and will absorb rallies until cleared.
• Sell-side turned negative: Weiss Ratings downgraded to Sell (D+) on June 29, 2026 citing deteriorating fundamentals the opposite of the clustered-upgrade acceleration this playbook wants.
• GAAP deteriorating under the EBITDA gloss: Q1 2026 GAAP net loss widened to $16M from $7M a year earlier even as operational EBITDA improved; Q1 cash fell $38M on a silver/aluminum-driven inventory build plus a $50M term-loan repayment.
• AM&C growth is the wrong slope: AM&C revenue +3% YoY in Q1 2026 ($76M vs $74M), trailing Print's +9% and far short of a "meaningful 2H-2026 offtake" inflection; no named, signed battery offtake was disclosed on the May 7 call.
• The squeeze leg is gone: short interest sits near ~5.6M shares the retail-squeeze dynamic that amplified the April/May move is no longer present.

Setup & Price Structure

The structure is broken, not basing. Sequence: ~$6 March base → $12.48 (Apr 29) → $14.87 52-week high (May 4) → correction through the $9.06 June low → loss of the $9.00 shelf → a new $4.94 52-week low on the July dilution news → a partial recovery to ~$7.78 (July 16, prior close $8.06 July 15, day range $7.73–$8.04). Price sits below its declining short-term moving averages and near the rising 200-day / prior-base region around $7. This is the beginner-trap zone the playbook explicitly warns on: a "cheap, net-cash" name after a hard break invites averaging into a value trap, and a 5%-below-high bounce into a live 39.46M-share resale overhang is exactly the supply a fresh long gets sold into. There is no higher-low reclaim yet, no clustered upgrades, and no accelerating narrative the tape is post-mania digestion at best and continuation lower at worst. Stand aside until a clean higher-low forms above the lost shelf on volume; do not chase or average down.

Catalyst Calendar (next 30 days)

• 2026-08-11 (confirmed) Q2 2026 earnings. The binary: watch AM&C sequential revenue and any named/signed battery offtake, GAAP loss trajectory vs the $16M Q1 loss, and cash after the Q1 $38M draw. Respect a 3-trading-day pre-print blackout (no fresh entries after ~2026-08-06 close).
• Ongoing (not a dated event) the July 1, 2026 resale registration (up to ~39.46M shares) is a standing supply overhang; any rally is likely met with issuance until it is absorbed. The $100M ATM shelf (filed Nov 2025) caps upside on strength.
• Nothing else scheduled inside 30 days; the Dec 2, 2025 pension reversion is realized and in the price not an upcoming catalyst.

What Would Change Our Mind

• A reclaim of the lost ~$9.20 June shelf on above-average volume with the resale overhang visibly absorbed would rebuild a fresh higher-low long setup worth a probe.
• A named, signed battery-electrode offtake (Ateios/RaiCore with a disclosed OEM) or AM&C revenue re-accelerating to double-digit YoY on the Aug 11 print would convert the pivot from story to catalyst.
• Clustered analyst upgrades reversing the June 29 Sell call, or a strategic-review/carve-out announcement leveraging the net-cash balance sheet, would restore the special-situation thesis.
• Absent those, cheapness and a clean balance sheet are not a reason to buy a broken tape into a dilution shelf.

Correlation Notes

KODK is an idiosyncratic special situation with low, unreliable correlation (~0.35–0.45) to rare-earth/battery-materials peers do not assume it joins any materials or clean-energy rally automatically; demand tape confirmation before treating peer strength as a tell. Its true input-cost sensitivity is to silver and aluminum, which drove the Q1 inventory build and margin pressure, so commodity spikes are a margin headwind, not a narrative tailwind. Beta to the broad tape is muted relative to its own event calendar; the stock trades on filings (reversion 8-Ks, resale registrations) and the earnings print far more than on sector flow.